Yttrium (90Y) tacatuzumab tetraxetan

Yttrium (90Y) tacatuzumab tetraxetan
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target α-fetoprotein
Identifiers
CAS Number 476413-07-7 N
ATC code none
ChemSpider none
Chemical data
Formula C6470H9971N1712O2007S4290Y
Molar mass 145 kg/mol
 NYesY (what is this?)  (verify)

Yttrium (90Y) tacatuzumab tetraxetan (trade name AFP-Cide) is a humanized monoclonal antibody intended for the treatment of cancer.[1] The antibody itself, tacatuzumab, is conjugated with tetraxetan, a chelator for yttrium-90,[2] a radioisotope which destroys the tumour cells.

References


This article is issued from Wikipedia - version of the Sunday, April 03, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.